Philadelphia, PA, United States of America

Bogoljub Ciric

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2012-2016

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Bogoljub Ciric

Introduction

Bogoljub Ciric is a notable inventor based in Philadelphia, PA, who has made significant contributions to the field of immunology. With a focus on enhancing immune responses, Ciric has developed innovative solutions that have the potential to impact medical treatments and therapies.

Latest Patents

Ciric holds 2 patents that showcase his expertise in antibody development. His latest patents describe a recombinantly produced antibody capable of potentiating immune responses and modifying existing states of immune responsiveness. The patents detail the sequence of the antibody and include compositions containing the antibody, as well as methods for using the antibody and the compositions to enhance immune responses, improve dendritic cell function, immunize individuals, and treat or inhibit conditions such as allergic asthma.

Career Highlights

Ciric is affiliated with the Mayo Foundation for Medical Education and Research, where he continues to advance his research and development efforts. His work is characterized by a commitment to improving health outcomes through innovative scientific approaches.

Collaborations

Throughout his career, Ciric has collaborated with esteemed colleagues, including Larry R Pease and Virginia Van Keulen. These partnerships have contributed to the success and impact of his research initiatives.

Conclusion

Bogoljub Ciric's contributions to immunology through his innovative patents and collaborations highlight his role as a significant figure in the field. His work continues to pave the way for advancements in medical science and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…